EE538 Once-Weekly Icodec Versus Basal Insulin Analogs for the Treatment of Type 2 Diabetes in the UK: A Long-Term Cost-Effectiveness Analysis Based on a Post-Hoc Analysis of the Onwards 5 Clinical Trial
Abstract
Authors
A Tyagi J Cattin S Malkin B Hunt B Chubb